MarketPeel
Insider Trading Intelligence
Pricing
…
KK

Karen Krasney

CAPR
EVP, GENERAL COUNSEL · CAPRICOR THERAPEUTICS, INC. · CIK 0001593086
FILING MIX · LIFETIME53%/47%
BUYS
25
SELLS
22
TOTAL VALUE
$2.59M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
30,547
AVG SELL PX
$30.73
TRADE KIND
SHOWING 47 / 47
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 7 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Karen Krasney, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+1.73%+1.86%-0.14%-0.14%—
14d2+50.00%+6.02%+4.89%+1.13%+1.13%—
30d2+50.00%+3.69%+10.51%-0.04%-0.04%—
60d2+100.00%-13.25%+2.82%-25.08%-25.08%—
90d2(1 pending)+100.00%-13.03%+12.09%-25.12%-25.12%—
180d2(2 pending)——————
1y2(2 pending)——————
2y2(2 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CAPR · 30,547 shares · as of Jun 25, 2026
026,22752,45478,681104,908202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 22 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
24,100$30.38$732.2K30,547Jun 25, 2026Jun 29, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
24,100——31,261Jun 25, 2026Jun 29, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
24,100$3.18$76.6K54,647Jun 25, 2026Jun 29, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
400$3.18$1.3K30,947Jun 24, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
400$30.00$12.0K30,547Jun 24, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
400——55,361Jun 24, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
500$3.18$1.6K31,047Jun 22, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
500$30.00$15.0K30,547Jun 22, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
500——55,761Jun 22, 2026Jun 24, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
25,000$3.18$79.5K55,547May 1, 2026May 4, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
25,000——56,261May 1, 2026May 4, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,000$31.70$792.5K30,547May 1, 2026May 4, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,000$30.12$752.9K30,547Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
2,819$3.18$9.0K55,547Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
693——2,807Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
2,819——81,261Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
21,488$3.74$80.4K52,728Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
693$1.39$96331,240Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
21,488——74,205Mar 31, 2026Apr 1, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,500——22,500Jan 5, 2026Jan 7, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
2,500$1.39$3.5K30,547Dec 30, 2025Mar 27, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
2,500——0Dec 30, 2025Mar 27, 2026 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,000——60,000Jan 2, 2025Jan 6, 2025 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
8,000$1.39$11.1K28,047Dec 13, 2024Dec 16, 2024 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
5,000——0Dec 13, 2024Dec 16, 2024 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
3,000——0Dec 13, 2024Dec 16, 2024 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,140——7,140Jan 2, 2024Jan 4, 2024 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,000——80,000Jan 2, 2024Jan 4, 2024 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,878——11,878Jan 3, 2023Jan 5, 2023 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,000——80,000Jan 3, 2023Jan 5, 2023 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
18,932——0Nov 3, 2022Nov 4, 2022 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASE
EVP, GENERAL COUNSEL
18,932$1.39$26.3K20,047Nov 3, 2022Nov 4, 2022 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
84,080——84,080Jan 3, 2022Jan 4, 2022 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
95,693——95,693Jan 4, 2021Jan 6, 2021 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
104,908——104,908Jun 5, 2020Jun 9, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
18,932——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
18,932——18,932Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
5,000——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
14,000——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,500——3,500Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
2,500——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,500——2,500Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,000——3,000Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
3,000——0Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,000——14,000Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,000——5,000Feb 12, 2020Feb 14, 2020 ↗View →
CAPR
CAPRICOR THERAPEUTICS, INC.
SALE
EVP, GENERAL COUNSEL
3,500——0Feb 12, 2020Feb 14, 2020 ↗View →
Other insiders · CAPR
Loading peer insiders…
About this filer
CIK 0001593086
ROLE
EVP, GENERAL COUNSEL
PRIMARY
CAPR
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001593086DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback